Merck KGaA (PK) (MKKGY) News

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Form 8-K - Current report

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14A - Other definitive proxy statements

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Amended Annual Report (10-k/a)

0001022899 true FY Amendment No. 1 Protagenic Therapeutics, Inc.new 0001022899 2022-01-01...

Current Report Filing (8-k)

0001022899 false --12-31 Protagenic Therapeutics, Inc.new 0001022899 2023-03-21 2023-03-21...

Quarterly Report (10-q)

0001022899 false Q3 --12-31 Protagenic Therapeutics, Inc.new

Proxy Statement (definitive) (def 14a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A...

Quarterly Report (10-q)

0001022899 false Q2 --12-31 Protagenic Therapeutics, Inc.new

Quarterly Report (10-q)

0001022899 false Q1 --12-31 2022 Protagenic Therapeutics, Inc.new

Securities Registration: Employee Benefit Plan (s-8)

  As filed with the Securities and Exchange Commission on March 8, 2022   Registration No. ___________    ...

Statement of Ownership (sc 13g)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549    ...